简介：
Overview
This study presents a detailed protocol for generating human induced pluripotent stem cell-derived brain organoids aimed at modeling mitochondrial diseases. The methodology described allows for the reproducible assessment of mitochondrial properties without the need for costly bioreactors or complex embedding processes.
Key Study Components
Area of Science
- Stem Cell Biology
- Neuroscience
- Mitochondrial Disease Modeling
Background
- Human induced pluripotent stem cells (iPSCs) provide a versatile platform for generating organoids.
- Mitochondrial diseases are often challenging to study due to the complexity of associated cellular mechanisms.
- Current modeling approaches can be resource-intensive and not easily scalable.
- Understanding mitochondrial functionalities in brain organoids can lead to potential therapeutic targets.
Purpose of Study
- To provide a straightforward protocol for generating brain organoids from human iPSCs.
- To evaluate mitochondrial properties in these organoids.
- To facilitate the study of interventional targets for mitochondrial diseases.
Methods Used
- Utilized human iPSC-derived brain organoids for mitochondrial property assessment.
- The protocol supports scalable production and does not rely on complex equipment.
- Detailed methodology includes culturing iPSCs, differentiation processes, and organoid maturation timelines up to day 70.
- Organoids were fixed and analyzed for neuronal and glial cell markers.
Main Results
- Successfully produced mature brain organoids containing both neuronal and glial cells.
- Characterization of organoids included visualization of axonal and dendritic structures, as well as mitochondrial marker staining.
- Demonstrated methods for evaluating mitochondrial bioenergetics using oxygen consumption rates.
Conclusions
- This protocol enables effective modeling of mitochondrial diseases using brain organoids.
- Facilitates the understanding of mitochondrial functions in neuronal contexts.
- Impacts future research directions for therapeutic interventions in mitochondrial dysfunction.
What are the advantages of using brain organoids in research?
Brain organoids closely mimic in vivo brain structures and functions, making them valuable for studying complex neurological diseases and cellular mechanisms.
How can human iPSCs be cultured for this protocol?
Human iPSCs are cultured under feeder-free conditions in iPSC medium, maintaining specific temperature and atmospheric conditions for optimal growth.
What types of cellular readouts can be obtained from the brain organoids?
Molecular readouts include the assessment of neuronal and glial cell markers, mitochondrial properties, and bioenergetic profiles.
How does this protocol support scalability in research?
The method does not involve expensive bioreactors or complicated protocols, allowing researchers to easily upscale organoid production.
What are the key limitations of this protocol?
While the protocol simplifies organoid generation, potential variability in organoid maturity and functionality could impact reproducibility across different studies.
How are mitochondrial properties analyzed in the organoids?
Mitochondrial properties are evaluated through bioenergetic profiling, including measuring oxygen consumption and extracellular acidification rates.
繁體中文
